Stock Events

Stock Events

Search...

Alnylam Pharmaceuticals (ALNY) Q3 2018 Earnings

2AugConfirmed

Q4 2017

Q1 2018

Q2 2018

Q3 2018

-1.83

-1.64

-1.46

-1.27

Details

Expected EPS

-1.72

Actual EPS

-1.83

Surprise EPS

-0.11

Surprise Percent

+6.4%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.83 per share for Q3 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.